WO2026062552 - NEBULIZATION COMPOSITION COMPRISING GLYCOPYRROLATE, FORMOTEROL AND BUDESONIDE
National phase entry is expected:
Publication Number
WO/2026/062552
Publication Date
26.03.2026
International Application No.
PCT/IB2025/059379
International Filing Date
18.09.2025
Title **
[English]
NEBULIZATION COMPOSITION COMPRISING GLYCOPYRROLATE, FORMOTEROL AND BUDESONIDE
[French]
COMPOSITION POUR NÉBULISATION COMPRENANT DU GLYCOPYRROLATE, DU FORMOTÉROL ET DU BUDÉSONIDE
Applicants **
GLENMARK PHARMACEUTICALS LIMITED
Inventors
DHUPPAD, Ulhas
CHAUDHARI, Sunil
RAJURKAR, Suresh
Priority Data
202421070954
19.09.2024
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2237 | |
| EPO | Filing, Examination, Granting | 12810 | |
| Japan | Filing, Examination, Granting | 2215 | |
| South Korea | Filing, Examination, Granting | 2265 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
24,267
Contact Us
Abstract[English]
The present application relates to an inhalable liquid composition suitable for nebulization comprising a fixed dose combination comprising glycopyrronium, formoterol and budesonide for treating a pulmonary disorder(s). The present application also relates to a process for preparing such a composition comprising a fixed dose combination comprising glycopyrronium, formoterol and budesonide.[French]
La présente demande concerne une composition liquide inhalable appropriée pour la nébulisation comprenant une association à dose fixe comprenant du glycopyrronium, du formotérol et du budésonide pour le traitement d'un ou plusieurs troubles pulmonaires. La présente demande concerne également un procédé de préparation d'une telle composition comprenant une association à dose fixe comprenant du glycopyrronium, du formotérol et du budésonide.